CFDB - Cystic Fibrosis DataBase

HTA - Health Technology Assessment Report

Colistimethate sodium powder for inhalation (Colobreathe) for pseudomonas aeruginosa lung infection in cystic fibrosis

Participants

CF patients with Pseudomonas aeruginosa lung infection (including colonisation)

Interventions

Colistimethate sodium powder for inhalation (Colobreathe) administered twice daily

Keywords: Anti-Bacterial Agents; Bacterial Infections; colistimethate; Colistin; Infection; Inhalation OR nebulised; pharmacological_intervention; Powders; Pseudomonas aeruginosa; Pseudomonas; Respiratory Tract Diseases; Respiratory Tract Infections; other anti-bacterial agents;